Overview

Donepezil, Residual Excessive Daytime Sleepiness, Obstructive Sleep Apnea

Status:
Unknown status
Trial end date:
2019-03-02
Target enrollment:
Participant gender:
Summary
It is a randomized, double-blind, single-center, 30-day study. Patients aged 35-60 years, with apnea and hypopnea index and respiratory disturbance index normalized with CPAP, and Epworth Sleepiness Scale> 11. Patients undergo baseline and CPAP titration polysomnography, liquor and blood collection, Multiple Sleep Latency Test, anxiety and depression and cognitive assessments.
Phase:
Phase 4
Details
Lead Sponsor:
Associação Fundo de Incentivo à Pesquisa
Treatments:
Donepezil